Would be very interested in how others define "hold" orders in policy.

Thanks!

Do any of your facilities use diazepam in the PACU to treat withdrawal in your ambulatory surgery centers? If so, is it stocked for all cases or only limited to 23:59?

Thank you

We are currently in the process of identifying PI projects for 2019. BCMA is receiving a lot of attention at our institution and an area where we may have opportunities for performance improvement. To facilitate brainstorming, can others offer BCMA related PI projects they have previously completed at other institutions? Thanks!

Hi all -

I've been asked by my leadership to create a scope of services document. Does anyone have one that they're willing to share? Additionally, they specifically want our scope of service as it relates to nursing. Does anyone have that specifically called out?

Thanks,
Elizabeth

We are exploring smart pump options with an eye towards EMR interoperability. While we have some limited experience with older models of Alaris and Hospira Plum pumps, we're very interested in what the group has to offer in the way of insight and wisdom.

What questions should prospective purchasers be asking when assessing:
1. Usability
2. Safety features
3. Interoperability
4. Complex programming

I wanted to see how other institutions, including health systems, structure the medication pump libraries. We currently have 4 different vendors for our large volume, syringe, epidural, and PCA pumps. Each pump has it's own subcommittee and chair that report to a larger multidisciplinary pump committee. Currently, the medication safety officer is the chair of the pump committee and in charge of all library maintenance, including upgrades.
I would love to hear how other institutions handle the pump libraries.
Thanks -
Maria Cumpston, PharmD, CPPS

As a matter of curiosity I'm interested in how other institutions are handling the Designated Person requirement in USP 800

1) Is your DP only responsible for USP 800 implementation or do they have other responsibilities?
2) How many FTEs do you have assigned to the DP role?
3) Does your DP draft the non-pharmacy related procedures?

Thanks!

Hi there!

Just curious if anyone has any unique systems developed for management of REMS medications throughout their healthcare system?

Does your organization have a pharmacist check all non-patient specific ADC replenishments (pyxis, omnicell...etc)?

If not, do you use a tech validation or tech-check-tech program? and\or do you rely on barcode technology on dispense and fill?

We have always had a pharmacist check pyxis replenishment stock and have not (re)-evaluated in a number of years since incorporating barcode validation on dispense, and on pyxis fill.

appreciate others perspective and any value added accounts of having a pharmacist check pyxis stock.

Nick Haar

Hello,

I’m interested in seeing if any of my colleagues at other facilities have been experiencing an increase in adverse events associated with the use of IV contrast in neurointerventional endovascular procedures.

To summarize briefly, we have recently observed an increase in events where these patients have experienced symptoms of stroke, seizure and encephalopathy post neurointerventional procedures with subsequent recovery. One common feature among these patients is the unexpected presence of IV contrast in the brain post procedure.